COMPANY

Delpor, Inc.

HQ: Brisbane, CA source · delpor.com ↗

Also known as Delpor · 2 sources

Keywords: neurology psychiatry medical device sustained release Opiod Use Disorder Schizophrenia Risperidone

Location: Brisbane, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Timeline

Mar 22, 2022 Trial start Phase 1: Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160) source ↗
Apr 1, 2021 Trial start Phase 1/Phase 2: Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT05304364	Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)	Phase 1	Completed	Mar 22, 2022	Oct 21, 2022 (actual)
NCT04418466	Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant	Phase 1/Phase 2	Completed	Apr 1, 2021	Feb 10, 2023 (actual)